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Abstract 
To estimate the surgical volume and the incidence of in-hospital complications of RC in Armenia from 2005 to 2012, 
and to investigate potential risk factors of complications. The study utilized a retrospective chart review in a cohort of 
patients who had RC followed by either continent or conduit urinary diversion in all hospitals of Armenia from 2005 to 
2012. A detailed chart review was conducted abstracting information on baseline demographic and clinical charac-
teristics, surgical procedural details, postoperative management and in-hospital complications. Multivariable logistic 
regression analysis was applied to estimate the independent risk factors for developing ‘any postoperative complica-
tion’. The total study sample included 273 patients (mean age = 58.5 years, 93.4 % men). Overall, 28.9 % (n = 79) of 
patients had at least one in-hospital complication. The hospital mortality rate was 4.8 % (n = 13). The most frequent 
types of complications were wound-related (10.3 %), gastrointestinal (9.2 %) and infectious (7.0 %). The ischemic heart 
disease (OR = 3.3, 95 % CI 1.5–7.4), perioperative transfusion (OR = 2.0, 1.1–3.6), glucose level [OR = 0.71 (0.63–0.95)], 
and hospital type (OR = 2.3, 95 % CI 1.1–4.7) were independent predictors of postoperative complications. The rate 
of RC complications in Armenia was similar to those observed in other countries. Future prospective studies should 
evaluate the effect of RC complications on long-term outcomes and costs in Armenia. Policy recommendations 
should address the issues regarding surgeon training and hospital volume to decrease the risk of RC complications.
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Background
Urinary bladder cancer is the most often occurring can-
cer in the urinary system ranking ninth in overall can-
cer incidence worldwide (Parkin 2008; Janković and 
Radosavljević 2007). The reported incidence of bladder 
cancer varies widely between countries and reporting 
sources, mostly due to differences in disease classification 
(Parkin 2008; Crow and Ritchie 2003).
According to 2011 national statistics, in Armenia the 
incidence rate of bladder cancer was 23.9 per 100,000 
population among men and 1.8 among women (National 
Information Analytic Centre 2012). According to world-
wide incidence statistics, in 2012 Armenia was ranked 
12th in age-standardized incidence of bladder cancer 
when considering both sexes (12,3/100,000) and 4th 
when considering males (27.3/100,000) (Ferlay et  al. 
2014). Among other important risk factors (e.g., age, 
occupation, genetic predisposition, schistosomiasis), 
smoking is the most important contributing factor for 
developing bladder carcinoma, with an established popu-
lation attributable risk of 50 % in men and 52 % in women 
(Parkin 2008; Janković and Radosavljević 2007; Freedman 
et al. 2011). Armenia has the third highest smoking prev-
alence rate in the world at 27  % prevalence in the total 
population, with 52  % in males and 1.7  % in females in 
2012 (Ng et al. 2014).
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Bladder cancer mortality rates vary depending on its 
stage at the time of diagnosis (i.e., localized, regional or 
distant) with an overall 5-year disease-specific survival 
approaching 81 % (Abdollah et al. 2013). At the time of 
diagnosis, 30  % of bladder cancers are already muscle 
invasive and require a combined treatment of surgery 
with chemotherapy and/or radiation therapy (Witjes 
et  al. 2014). The surgery includes radical cystectomy 
(RC) with regional bilateral lymph node dissection, and 
carries high risk of early and late complications due to 
simultaneous involvement of urinary tract, intestines, 
lymph nodes and the type of urinary diversion (Witjes 
et  al. 2014). In the published literature, the proportion 
of patients experiencing at least one early in-hospital 
complication after RC varies from 26 to 67 %, with the 
in-hospital mortality varying from 0.6 to 2.6  % (Hol-
lenbeck et  al. 2005; Konety et  al. 2006; Novotny et  al. 
2011; Shabsigh et al. 2009). The reported proportion of 
patients with complications within 90 days of the index 
hospitalization varies from 58 to 64  %, and mortality 
from 2.3 to 2.7 % (Shabsigh et al. 2009; Hautmann et al. 
2010). These postoperative complications are associ-
ated with longer hospital length of stay (LOS), increased 
costs of care and mortality (Novotny et al. 2011; Konety 
and Allareddy 2007). Early perioperative outcomes vary 
by the type of urinary diversion with diversion-unre-
lated complications being high in the ureterocutaneos-
tomy patients and diversion-related complications in 
continent and conduit diversion patients (Pycha et  al. 
2008).
Unlike many other countries, there are no comprehen-
sive population-based, administrative or clinical data-
bases in Armenia to capture patient care processes. So, 
it is unclear at what stages patients are referred to sur-
gery, what are their outcomes, and if there have been any 
changes over time. The aim of the present study was to 
estimate the surgical volume of RC conducted for blad-
der cancer in Armenia from 2005 to 2012, assess the 
incidence of early postoperative (in-hospital) compli-
cations, and investigate potential risk factors for these 
complications.
Results
We identified eight hospitals that performed RC in 
Armenia, all of which were located in Yerevan (i.e., none 
of the hospitals outside the capital had capacity to per-
form RC). All but one hospital performing 1–2 surgeries 
per year agreed to participate in the study. The medical 
records of all patients who had RC followed by either 
continent or conduit urinary diversion between 2005 and 
2012 in these seven hospitals have been reviewed. After 
excluding 50 patients with bilateral uretrocutaneostomy, 
the total sample included 273 patients.
Table 1 presents patient baseline and operative charac-
teristics. The average age of the patients was 58.5  years 
[standard deviation (SD) = 8.9] and the majority (93.4 %) 
were men. Approximately 77 % of patients lived in urban 
areas. Most patients (63 %) had their surgery in hospital 
A. As the total number of patients was less than ten in 
four hospitals for the reviewed time period, they have 
been collapsed into ‘Other’ category for the analysis. 
While smoking history was missing in 34  % of medical 
records, the proportion of current smokers was quite 
high in those with complete data (74  %). In the major-
ity of patients, cancer was confined to bladder (56.6 %). 
About 86 % have had continent urinary diversion.
Postoperative (in‑hospital) complications
In total, 79 patients (28.9  %) developed at least one 
postoperative complication (Table  2). Among patients 
with complications, 54 (19.8  %) had one complication, 
20 (7.3  %) had two and 5 (1.9  %) patients had three or 
more. The most commonly occurring complications were 
wound-related (n = 28 patients), followed by gastrointes-
tinal (GI) (n = 25), and infectious complications (n = 19). 
Some complications were potentially life-threatening 
including sepsis observed in 0.7  %, myocardial infarc-
tion in 1.5 %, pulmonary embolism in 1.5 %, disseminated 
intravascular coagulation in 0.3  %, and stroke in 0.3  % 
of the sample. The in-hospital mortality rate was 4.8  % 
(n = 13) and all patients that died developed at least one 
complication before death.
Compared to patients without complications, those 
who developed complications were more likely to have 
ischemic heart disease (IHD), lower blood glucose levels 
prior surgery, and higher anesthetic risk (Table 1). About 
57  % of patients with complications had perioperative 
transfusion of red blood cells or fresh frozen plasma 
compared to 32  % in patients without complications. 
Among patients discharged alive, patients with compli-
cations had significantly longer length of preoperative, 
postoperative and total hospital stays, which is shown 
in Additional file 1: Figure S1. For example, the average 
total hospital LOS was 36 days (SD = 18) in the full sam-
ple, 49 days (SD = 20) in patients with complications and 
32 days (SD = 15) in those without.
Predictors of postoperative complications
We selected eight candidate variables for inclusion into 
the multivariable logistic regression model: age, gender, 
hospital, IHD, creatinine, glucose, American Society of 
Anesthesiologists score, and any perioperative transfu-
sion of fresh frozen plasma or red blood cells (Table 3). 
The final model included four independent predictors 
(Table 3), and had acceptable calibration (Hosmer–Leme-
show goodness-of-fit test, X-squared = 5.9617 for df = 8, 
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Table 1 Patient preoperative and operative characteristics




In‑hospital complications  
n = 79
P value
Age (years), mean (SD) 58.5 (8.9) 58.6 (8.5) 58.3 (9.8) 0.82
Age (years), n (%) 0.18 
 <55 97 (35.5) 66 (34.0) 31(39.2)
 55–64 106 (38.8) 82 (42.3) 24 (30.4)
 ≥65 70 (25.6) 46 (23.7) 24 (30.4)
Male, n (%) 255 (93.4) 179 (92.3) 76 (96.2) 0.29
Place of living, n (%) 0.70
 Urban 210 (76.9) 148 (76.3) 62 (78.5)
 Rural 63 (23.1) 46 (23.7) 17 (21.5)
Hospital, n (%) <0.01
 A 172 (63.0) 132 (68.0) 40 (50.6)
 B 48 (17.6) 25 (12.9) 23 (29.1)
 C 34 (12.5) 28 (14.4) 6 (7.6)
 Otherb 19 (7.0) 9 (4.6) 10 (12.7)
Year of surgery, n (%) 0.58
 2011/12 57 (20.9) 37 (19.1) 20 (25.3)
 2009/10 86 (31.5) 60 (30.9) 26 (32.9)
 2007/08 81 (29.7) 61 (31.4) 20 (25.3)
 2005/06 49 (17.9) 36 (18.6) 13 (16.5)
BMI (kg/m2), mean (SD) 26 (4.6) 25.9 (4.5) 26.1 (5.0) 0.75
Current smoker, n (%) 133 (73.9) 96 (75.0) 37 (71.2) 0.59
Diabetes, n (%) 14 (5.1) 9 (4.6) 5 (6.3) 0.56
Hypertension, n (%) 52 (19.0) 37 (19.1) 15 (19.0) 0.99
Preoperative hydronephrosis, n (%) 67 (24.5) 49 (25.3) 18 (22.8) 0.67
Preoperative chemotherapy, n (%) 22 (8.1) 14 (7.2) 8 (10.1) 0.42
Any prior surgery, n (%) 105 (38.5) 76 (39.2) 29 (36.7) 0.70
Renal diseases, n (%) 49 (17.9) 34 (17.5) 15 (19.0) 0.78
Gastrointestinal diseases, n (%) 55 (20.1) 41 (21.1) 14 (17.7) 0.52
IHD, n (%) 38 (13.9) 20 (10.3) 18 (22.8) 0.01
COPD/asthma, n (%) 20 (7.3) 14 (7.2) 6 (7.6) 0.91
Other diseases, n (%) 51 (18.7) 37 (19.1) 14 (17.7) 0.80
Hemoglobin level (g/l), mean (SD) 134.1 (18.7) 133.5 (19.2) 135.5 (17.5) 0.43
Preoperative red blood cells count (×1012/L), mean (SD) 4.2 (0.6) 4.1 (0.6) 4.2 (0.5) 0.36
Preoperative white blood cells count (×109/L), mean (SD) 7.5 (2.1) 7.4 (1.9) 7.6 (2.6) 0.55
Preoperative creatinine level (mkm/L), mean (SD) 90.7 (24.8) 89.5 (24.6) 93.7 (25.2) 0.21
Preoperative glucose level (mmol/L), mean (SD) 5.7 (1.9) 5.8 (2.1) 5.2 (1.28) 0.01
Preoperative protein level (g/100 mL), mean (SD) 7.8 (0.6) 7.8 (0.59) 7.8 (0.58) 0.93
Preoperative fibrinogen (mg/100 mL), mean (SD) 430.2 (120.6) 430.9 (127.5) 428.4 (102.0) 0.87
Transurethral resection (TUR) in the past, n (%) 123 (45.1) 90 (46.4) 33 (41.8) 0.49
Preoperative cystoscopy, n (%) 76 (27.9) 48 (24.9) 28 (35.4) 0.08
Preoperative TUR biopsy, n (%) 60 (22.0) 39 (20.3) 21 (26.6) 0.26
Stage of the cancer, n (%) 0.57
 Bladder confined (pT1-2 pN0 M0) 154 (56.6) 113 (58.5) 41 (51.9)
 Locally Advanced (pT3-4a pN0 M0) 86 (31.6) 59 (30.6) 27 (34.2)
 Extravesical (pT4b/any pT with N1-N3 or M1) 32 (11.8) 21 (10.9) 11 (13.9)
Type of urinary diversion, n (%) 0.62 
 Continent 234 (85.7) 165 (85.1) 69 (87.3)
 Conduit 39 (14.3) 29 (14.9) 10 (12.7)
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Table 1 continued




In‑hospital complications  
n = 79
P value
ASA score, n (%) 0.01 
 1 or 2 180 (71.7) 135 (76.3) 45 (60.8)
 3 or 4 71 (28.3) 42 (23.7) 29 (39.2)
Anesthesia type (%) 0.05 
 General 38 (13.9) 22 (11.3) 16 (20.3)
 Combined general and epidural 235 (86.1) 172 (88.7) 63 (79.7)
Operative time (minutes), mean (SD) 325.6 (81.5) 322.6 (82.0) 333.0 (80.0) 0.34
Transfusion of RBCc, n (%) 80 (29.3) 53 (27.3) 27 (34.2) 0.26
Transfusion of FFPc, n (%) 55 (20.1) 21 (10.8) 34 (43.0) <0.01
Any transfusion (RBC/FFP)c, n (%) 107 (39.2) 62 (32.0) 45 (57.0) <0.01
ASA American Society of Anesthesiologists, BMI body mass index, COPD chronic obstructive pulmonary disease, ICU intensive care unit, IHD ischemic heart disease, 
FFP fresh frozen plasma, LOS length of stay, RBC red blood cells, SD standard deviation, TUR transurethral resection
a More than 5 % missing values present for the variables “Current smoker”(34 %), “BMI” (9 %), and “ASA” (8 %). For variables with missing values, calculations were 
made after excluding missing values
b Combined data from four hospitals
c Represents the number of patients with any intraoperative and/or postoperative transfusion
Table 2 Postoperative in-hospital complications (n = 273)
Category: n (%) Complication type n (%)
Wound: n = 28 (10.3) Wound infection 19 (7.0)
Wound dehiscence 9 (3.3)
Gastrointestinal: n = 25 (9.2) Postoperative ileus 20 (7.3)
Anastomotic bowel leak 3 (1.1)
Gastrointestinal bleeding 2 (0.7)
Infectious: n = 19 (7.0) Urinary tract infection 13 (4.8)
Postoperative sepsis 2 (0.7)
Peritonitis 4 (1.5)
Cardiac: n = 11 (4.0) Congestive heart failure 6 (2.2)
Myocardial infarction 4 (1.5)
Arrhythmia 1 (0.3)
Thromboembolic: n = 7 (2.6) Deep venous thrombosis 3 (1.1)
Pulmonary embolism 4 (1.5)
Pulmonary: n = 6 (2.1) Postoperative pneumonia 6 (2.1)
Genitourinary: n = 4 (1.5) Postoperative acute renal 
failure
3 (1.1)
Urinary leak 1 (0.3)






Miscellaneous: n = 3 (1.1) Lymphocele 3 (1.1)
Neurological: n = 2 (0.7) Ischemic stroke 1 (0.3)
Peripheral neuropathy 1 (0.3)
Surgical: n = 2 (0.7) Bowel perforation 2 (0.7)
Any complication: n = 79 
(28.9)
Table 3 Univariable and  multivariable analyses of  predic-
tors of postoperative complications
ASA American Society of Anesthesiologists, CI confidence interval, FFP fresh 
frozen plasma, IHD ischemic heart disease, OR odds ratio, RBC red blood cells
Variables Univariable analysis Multivariable analysis
OR (95 % CI) P value OR (95 % CI) P value
Age (years)
 <55 (reference) 1.00 –
 55–64 0.62 (0.33–1.16) 0.137





 Male 2.12 (0.68–9.36) 0.245
Hospital
 A (reference)
 B 3.67 (1.39–9.80) 0.009 2.05 (0.67–6.23) 0.20
 C 3.04 (1.56–5.94) 0.001 2.25 (1.07–4.70) 0.03
 Other 0.71 (0.25–1.73) 0.475 0.83 (0.28–2.11) 0.73
IHD 2.57 (1.27–5.18) 0.008 3.31 (1.48–7.44) <0.01
Creatinine 
(mkm/L)
1.00 (0.99–1.02) 0.215 –
Glucose 
(mmol/L)
0.76 (0.60–0.93) 0.014 0.71 (0.63–0.95) 0.02
ASA score
 1 or 2 (reference) –
 3 or 4 2.074 (1.15–3.70) 0.014
Any transfusion 
(RBC/FFP)
2.82 (1.65–4.85) <0.001 1.99 (1.10–3.64) 0.02
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P value = 0.652) and discrimination (area under the ROC 
curve, C-statistic  =  0.715). Based on adjusted analysis, 
IHD increased the odds of postoperative complications 
by more than three times (OR  =  3.3, 95  % confidence 
interval (CI) 1.5–7.4), any postoperative transfusion 
increased the odds twice (OR =  2.0, 95 % CI 1.1–3.64), 
patients in hospital C had more than twice higher odds 
of complications compared to hospital A (OR  =  2.3, 
95 % CI 1.1–4.7), and higher preoperative glucose levels 
decreased the odds of complications (OR = 0.7, 95 % CI 
0.6–1.0).
Discussion
The study established the surgical volume and incidence 
of in-hospital complications of RC for bladder cancer in 
Armenia from 2005 to 2012, and assessed the predictors 
of these complications. To our knowledge this was the 
first study conducted in Armenia among patients with 
RC, with reasonable generalizability to the entire popula-
tion of patients in Armenia for the specified time period. 
We found that 273 patients had RC in eight Armenian 
hospitals, and the incidence of postoperative complica-
tions and mortality was quite substantial.
Except age, the baseline profile of Armenian patients 
was not very different from those in other countries 
(Konety et al. 2006; Stimson et al. 2010; Kim et al. 2012; 
van Hemelrijck et al. 2013; Aziz et al. 2014). At the time 
of surgery Armenian patients were 58.5  years old on 
average. The average age of 679 RC patients in 18 Euro-
pean centers in 2011, for example, was 70  years (Aziz 
et al. 2014), and the average age of 50,625 RC patients in 
the US Nationwide Inpatient Sample from 2001 to 2008 
was 68.4 years (Kim et al. 2012). This indicates that blad-
der cancer may affect Armenian patients at younger ages. 
Armenian men also get exposed to smoking, the major 
risk factor of bladder cancer, at quite a young age. In 
2001, the average age of smoking initiation was 18.5 in 
Armenia men and 28.0 in women (Gilmore et al. 2004). 
In our study, about 74 % of patients reported being cur-
rent smokers, and smoking continues to be a major pub-
lic health problem in Armenia.
The observed in-hospital mortality rate in our sam-
ple was 4.8 %, somewhat higher than the mortality rates 
reported in other studies (Konety et  al. 2006; Shabsigh 
et al. 2009; Kim et al. 2012; Maffezzini et al. 2008). How-
ever, it is hard to conclude if this is Han indication of a 
sicker Armenian surgical population or inadequate pre- 
or postoperative management. Furthermore, the pro-
portion of patients developing at least one postoperative 
complication was 29 %, well within the range of reported 
complication rates in other studies that varied from 21.8 
to 57 % (Konety et al. 2006).
The most common complications observed in our 
study were postoperative ileus (7.3  %), followed by 
wound infections (7.0 %), urinary tract infections (4.8 %), 
and wound dehiscence (3.3  %). The study in 2538 RC 
patients by Hollenbeck et  al. similarly reported the top 
four most common complications as ileus (9.7  %), uri-
nary tract infections (7.8  %), wound dehiscence (5.5  %), 
and wound infections (5.2  %) (Hollenbeck et  al. 2005), 
though this study included a relatively older patient pop-
ulation (65.5 years old) (Hollenbeck et al. 2005). Using a 
reporting methodology by Shabsigh et al. (Shabsigh et al. 
2009), we found that wound complications had the high-
est incidence in our study population affecting 10  % of 
patients, followed by GI complications (9 %), and infec-
tious complications (7  %). Shabsigh et  al. also reported 
that these three complication categories were the most 
frequently occurring in a hospital in New York; however, 
GI complications were observed in 29  %, infectious in 
25 % and wound complications in 15 % of patients (Shab-
sigh et al. 2009). In the study by Takada et al. among Japa-
nese RC patients the highest incidence was observed for 
infectious complications (30  %), followed by GI (26  %) 
and wound (21  %) complications (Takada et  al. 2012). 
These two studies, however, captured 90-day complica-
tions (Shabsigh et al. 2009; Takada et al. 2012) while we 
recorded only in-hospital complications.
Similar to other past studies, we found that postopera-
tive complications significantly increase the hospital LOS 
of patients (Shabsigh et  al. 2009; Konety and Allareddy 
2007). Shabsigh et  al. reported that LOS is increasing 
with the increase of the severity of complications (Shab-
sigh et al. 2009). Another study further reported that the 
addition of each complication significantly increased the 
risk of in-hospital mortality, LOS and costs (Konety and 
Allareddy 2007). The total hospital LOS in our patient 
sample was higher than in other studies, which could 
be explained by differences in healthcare systems (Shab-
sigh et  al. 2009; Konety and Allareddy 2007; Maffezzini 
et al. 2008). Since all centers that conduct RC in Arme-
nia are located in the capital city, patients from remote 
areas stay longer until they recover and are fit to travel. 
Furthermore, in Armenia medical costs are mostly cov-
ered by patients and the major cost driver is the cost of 
the surgery and not the length of hospital stay after the 
procedure.
Not all risk factors identified by our literature review 
have been proven to be predictive of RC complica-
tions in Armenia. For example, several studies reported 
an increased risk of postoperative complications with 
increasing age (Hollenbeck et al. 2005; Konety et al. 2006; 
Kim et al. 2012; Gore et al. 2010). This was not true for 
the Armenian population, most probably because of a 
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relatively younger patient population. The risk of RC 
complications by gender has been controversial in the lit-
erature with some studies reporting an increased risk for 
females (Shabsigh et al. 2009; Gore et al. 2010), increased 
risk for males (Kim et al. 2012; Takada et al. 2012), or no 
risk difference (Konety et al. 2006; Lee et al. 2004) as in 
our sample.
The evidence is controversial regarding the issue of sur-
gical volume and patient outcomes. While some studies 
supported the positive impact of higher surgical case-
load and hospital volume on RC outcomes (Kim et  al. 
2012; McCabe et  al. 2007), others showed no difference 
(Konety et al. 2006; Takada et al. 2012; Gore et al. 2010). 
There is no unified approach to define high-, medium- or 
low-volume hospital categories for RC. The study by Kim 
et  al. in 1173 US hospitals found that patients in high 
volume hospitals (defined as ≥5RC/year) had 33  % less 
chance of in-hospital complications and 40 % less chance 
of in-hospital mortality than patients treated in low vol-
ume hospitals (defined as <1.5 RC/year) (Kim et al. 2012). 
Another study that defined >10 RC/year as high, 5–10 
as medium and ≤5 as low-volume hospitals, found no 
association between volume and risk of complications 
(Takada et al. 2012). A recent US study reported that sur-
geons who perform ≥7 RC per year had 44 % lower odds 
of major complications at 90 days than those performing 
1 RC per year (Leow et  al. 2015). We, however, did not 
capture per surgeon surgical volume. In our sample, the 
majority of patients underwent surgery in one of the hos-
pitals, hospital A, where the RC volume was on average 
22/year. The RC volume was 6, 4 and <1 per year in hos-
pital B, C, and in ‘other’ category. The odds of complica-
tions were almost twice higher in patients in hospital C 
than in hospital A.
ASA scores above 2 have been shown to increase the 
risk of RC complications (Hollenbeck et al. 2005; Novo-
tny et al. 2011; Shabsigh et al. 2009; Takada et al. 2012). 
In our study, ASA score was not an independent predic-
tor of complications. The comorbidities that have been 
shown to increase the risk of complications are also vari-
able between published studies (Hollenbeck et  al. 2005; 
Novotny et al. 2011; Kim et al. 2012; Takada et al. 2012; 
Gore et  al. 2010). Such differences can be explained by 
differences in the prevalence in the index population, in 
over- or under-reporting, and in peri-operative manage-
ment. In our sample, for example, although about 74  % 
of patients (with complete information) reported cur-
rent smoking history, the recorded prevalence of COPD 
was only 7 %. In our study IHD was one of the strongest 
predictors, increasing the odds of developing in-hospital 
complications by three times. Most past studies either 
did not capture IHD as a separate patient baseline factor 
(Konety et  al. 2006; Kim et  al. 2012), or captured other 
cardiovascular disease entities (Hollenbeck et  al. 2005; 
Gore et al. 2010). Considering our finding, we think that 
future studies should report the prevalence of IHD in this 
population and further investigate its effect on outcomes.
With detailed review of medical records we cap-
tured several pre-operative factors that are not available 
through administrative databases. In bivariate analysis, 
we found that patients without complications had signifi-
cantly higher glucose levels than those who developed in-
hospital complications. In multivariable analysis, higher 
glucose levels were associated with lower odds of com-
plications. Our review of past studies did not find any 
study in RC patient population that evaluated baseline 
glucose levels and their effect on surgical outcomes. Con-
sidering the retrospective nature of the study, it is impos-
sible to conclude if the low glucose levels are a result of 
advance cancer stages and derangements in carbohydrate 
metabolism. We were also unable to fully investigate the 
perioperative management of patients with low or high 
glucose levels.
Based on our findings, any intraoperative and/or post-
operative transfusion of fresh frozen plasma or red blood 
cells was another independent predictor, almost doubling 
the odds of post-operative complications. Intraoperative 
blood transfusion was a significant predictor of in-hospi-
tal complications in a study of 2538 RC patients by Hol-
lenbeck et  al. (OR =  1.4, 95  % CI 1.2–1.7) (Hollenbeck 
et  al. 2005). While several past studies did not report 
patient blood loss or transfusion of blood products (most 
likely because of the use of administrative databases that 
generally lack such data), transfusion of blood products 
has been shown to increase the risk of adverse surgical 
outcomes in cardiac surgery (Horvath et al. 2013), knee 
arthroplasty (Hart et al. 2014), and neurosurgery (Rolston 
et al. 2014).
Potential limitations of our study warrant discus-
sion. There is always some degree of variability in medi-
cal records and data capture methods between different 
hospitals. To minimize this, we used a standardized data 
collection tool. Smoking history, which was a variable 
of high interest, was not recorded in almost one third of 
medical records, and had to be excluded from adjusted 
analysis. As the information was collected retrospectively, 
it was impossible to accurately evaluate the amount of 
blood loss, the appropriateness of indications for transfu-
sions, and reasons and management of low glucose levels. 
At the same time, one of the major strengths of our study 
was the use of detailed clinical information from medical 
records that was somewhat limited in other studies that 
used administrative databases (Hollenbeck et  al. 2005; 
Konety et al. 2006; Kim et al. 2012; Gore et al. 2010). This 
allowed us to generate new hypotheses regarding the role 
of glucose levels and IHD in RC complications. We also 
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used a relatively recent cohort of patients, and obtained 
a national sample of RC patients. The results of our study 
can be used for comparisons with studies from other low 
or middle income countries.
Conclusion
The incidence of postoperative complications of RC in 
Armenia was similar to those observed in other coun-
tries. Coronary artery disease, receiving transfusion, 
glucose levels and hospital type were found to be inde-
pendent predictors of complications. Future prospective 
studies should evaluate the effect of RC complications 
on long-term outcomes and costs in Armenia. National 
guidelines should address the appropriateness of perio-
perative transfusion, and propose evidence-based man-
agement approaches for IHD patients. Surgical care 
pathways should be developed to standardize patient care 
in all centers. Policy recommendations should address 
surgeon training and hospital volume requirements to 
decrease the risk of RC complications.
Methods
The study utilized a retrospective chart review in a 
cohort of patients who had RC followed by either conti-
nent or conduit urinary diversion in Armenia from Janu-
ary 1, 2005 to December 31, 2012, following them from 
the day of index hospital admission for RC to the day of 
discharge or in-hospital death, whichever occurred first. 
We excluded patients with ureterocutaneostomy because 
these are mostly patients with reduced life expectancy 
(more advanced cancer stages) or multiple comorbidi-
ties with high risk of non-diversion related early postop-
erative complications (Pycha et al. 2008). We considered 
only cases with continent or conduit urinary diversion 
to have a more homogenous patient population in 
terms of postoperative complications related to bowel 
involvement.
To identify patients, first we selected all hospitals in 
the capital city of Armenia, Yerevan that had urologi-
cal departments and had a potential capacity to perform 
RC. Then we contacted the heads of the departments to 
establish if this surgery was performed in their hospitals 
and to inquire if they know of any other centers perform-
ing RC. The study timeframe was limited to 7  years to 
minimize the potential biases due to changes in clinical 
practice, care documentation, or healthcare regulations 
on observed outcomes.
Ethical approval
All procedures performed in studies involving human 
participants were in accordance with the ethical stand-
ards of the institutional research committee and with 
the 1964 Helsinki declaration and its later amendments 
or comparable ethical standards. The study protocol was 
approved by the Institutional Review Board of the Amer-
ican University of Armenia. For this type of study (retro-
spective study) formal individual patient consent was not 
required.
Data collection
We conducted a detailed medical chart abstraction of 
all patients in the sample. A previously described frame-
work for assessing postoperative complications after RC 
was used as a starting point to define data abstraction 
elements (Hollenbeck et  al. 2005). The framework cat-
egorizes data elements as preoperative risk factors (e.g., 
demographic characteristics, comorbidities, cancer stag-
ing), structure of care factors (e.g., year, hospital), process 
of care factors (e.g., perioperative transfusion, operative 
time), and outcomes (i.e., complications, mortality, length 
of stay). The final data dictionary was developed after a 
review of peer-reviewed literature and consulting con-
tent experts. Postoperative complications were catego-
rized following a standardized reporting methodology 
suggested by Shabsigh et al. (2009). One of the authors, a 
practicing urologist, pre-tested the data collection tool in 
10 patient records that were not part of the study. Then, 
for consistency in abstracting medical information, the 
same researcher used the data collection tool in all par-
ticipating hospitals.
Statistical analysis
All statistical analyses were performed using R software 
(R Core Team 2014 Foundation for Statistical Com-
puting, Vienna, Austria). Continuous variables were 
described using means and standard deviations, and cat-
egorical variables were described using frequencies and 
percentages. Independent t test or Wilcoxon test was 
used to compare continuous variables, and Chi square 
test to compare categorical variables. Loess smooth 
curves were used to investigate the relationship between 
the continuous variables and the outcome (i.e., postop-
erative complications). Multivariable logistic regression 
analysis was applied to estimate the independent risk 
factors of developing “any postoperative complication”. 
Candidate variables for the model were specified a priori, 
including predictors identified from the literature and 
those that were deemed clinically meaningful by content 
experts. Variables with more than 10  % missing values 
were not considered for the regression analysis. All can-
didate variables were first included into the model and 
then removed one by one using the log-likelihood ratio 
test and Akaike information criterion. Variables were 
tested for potential confounding, interactions and multi-
collinearity. Model fit was tested using diagnostic plots, 
the Hosmer–Lemeshow goodness-of-fit test, and area 
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under the receiver operating characteristic (ROC) curve 
(Hosmer et al. 2013). All results with the P value less than 
0.05 were considered statistically significant.
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